1.
Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD).
2.
3.
4.
5.
6.
7.
Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.
8.